RECORDATI GROUP
RECORDATI GROUP
Explore linked clinical trials.16 results · Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Post-Authorisation Safety Study Patient Registry of Patients With Neuroblastoma Being Treated With Dinutuximab Beta | Neoplasms by Histologic Type, Neoplasms by Site, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neuroectodermal Tumors, Primitive, Neuroectodermal Tumors, Primitive, Peripheral, brain disorder, central nervous system cancer, central nervous system disorder, epithelial neoplasm, neoplasm, nervous system disorder, neuroblastoma, neuroepithelial neoplasm, primitive neuroectodermal tumor | Active, not recruiting | Not stated | 2026-10-09 | NCT04253015 | |
| A Study of Melphalan With or Without Siltuximab in People With Multiple Myeloma Having an Autologous Stem Cell Transplant | Blood Protein Disorders, Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, cardiovascular disorder, hematologic disorder, hemorrhagic disease, immune system disorder, immunoproliferative disorder, lymphoproliferative syndrome, monoclonal gammopathy, neoplasm, plasma cell neoplasm, vascular disorder, vascular hemostatic disease | Recruiting | Phase 2 | 2026-10-01 | NCT06679829 | |
| Pasireotide s.c. in Patients With Post-Bariatric Hypoglycaemia | Post-Bariatric Hypoglycemia | Active, not recruiting | Phase 2 | 2026-09-17 | NCT05928390 | |
| A Block-and-Replace Therapy With Osilodrostat and Concomitant Glucocorticoid Replacement | Cushing syndrome, adrenal gland disorder, adrenal gland hyperfunction, adrenocortical insufficiency, endocrine system disorder, endogenous Cushing syndrome | Recruiting | Not stated | 2026-09-09 | NCT06430528 | |
| Screening Trial for Pain Relief in Schwannomatosis (STARFISH) | Chronic Pain, Neoplasms by Histologic Type, Neoplasms, Germ Cell and Embryonal, Neoplasms, Nerve Tissue, Neurologic Manifestations, Pain, Pathological Conditions, Signs and Symptoms, Signs and Symptoms, neoplasm, nerve sheath neoplasm, neuroendocrine neoplasm, neuroma, primitive neuroectodermal tumor, schwannoma, schwannomatosis | Recruiting | Phase 2 | 2026-07-24 | NCT05684692 | |
| Study of Cytokine Release Syndrome Prophylaxis and Treatment With Siltuximab Prior to Epcoritamab | Hemic and Lymphatic Diseases, Inflammation, Neoplasms by Histologic Type, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Shock, Systemic Inflammatory Response Syndrome, cytokine release syndrome, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, neoplasm, non-Hodgkin lymphoma | Recruiting | Phase 1 | 2026-06-25 | NCT06447376 | |
| Cold Agglutinin Disease Real World Evidence Registry | Hemic and Lymphatic Diseases, anemia, autoimmune disease, autoimmune hemolytic anemia, hematologic disorder, hemolytic anemia, immune system disorder | Active, not recruiting | Not stated | 2026-04-22 | NCT05791708 | |
| Pharmacokinetic (PK), Pharmacodynamic (PD) and Tolerability of Osilodrostat in Pediatric Patients With Cushing's Syndrome | Cushing syndrome, adrenal gland disorder, adrenal gland hyperfunction, brain disorder, central nervous system disorder, endocrine system disorder, hypothalamic disorder, nervous system disorder, pituitary gland disorder | Recruiting | Phase 2 | 2026-03-27 | NCT03708900 | |
| A Study of Pasireotide in People With Prolactinoma | Prolactin-Producing Pituitary Tumor | Recruiting | Phase 2 | 2026-03-04 | NCT06295952 | |
| Impact of 1 mg Osilodrostat Therapy on Mild Autonomous Cortisol Secretion (MACS) | Congenital Abnormalities, Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Cushing syndrome, Female Urogenital Diseases, Female Urogenital Diseases and Pregnancy Complications, Male Urogenital Diseases, Nutritional and Metabolic Diseases, Paraneoplastic Endocrine Syndromes, Urogenital Abnormalities, Urogenital Diseases, adrenal gland disorder, adrenal gland hyperfunction, adrenogenital syndrome, congenital adrenal hyperplasia, disorder of sexual differentiation, ectopic ACTH secretion syndrome, endocrine system disorder, gonadal disorder, hereditary disease, inborn errors of metabolism, metabolic disease, neoplasm, paraneoplastic syndrome, steroid inherited metabolic disorder | Recruiting | Phase 2 | 2026-02-11 | NCT07104812 | |
| Detecting Mild Autonomous Cortisol Secretion in Patients With Adrenal Incidentaloma | Mild Autonomous Cortisol Secretion (MACS) | Recruiting | Not stated | 2026-01-08 | NCT06344143 | |
| Osilodrostat in Patients With Hypertension Caused by Hypercortisolaemia Due to Cushing's Syndrome | Cushing syndrome, Paraneoplastic Endocrine Syndromes, adrenal gland disorder, adrenal gland hyperfunction, cardiovascular disorder, ectopic ACTH secretion syndrome, endocrine system disorder, hypertensive disorder, neoplasm, paraneoplastic syndrome, vascular disorder | Not yet recruiting | Phase 4 | 2025-12-10 | NCT07247162 | |
| Non-interventional Study on Osilodrostat in Patients With Endogenous Cushing's Syndrome | Cushing syndrome, adrenal gland disorder, adrenal gland hyperfunction, endocrine system disorder | Active, not recruiting | Not stated | 2025-11-20 | NCT05382156 | |
| Long-term Assessment of Chlormethine Gel in Mycosis Fungoides | Hemic and Lymphatic Diseases, Neoplasms by Histologic Type, T-cell non-Hodgkin lymphoma, immune system disorder, immunoproliferative disorder, lymphatic system disorder, lymphoma, lymphoproliferative syndrome, mycosis fungoides, neoplasm, primary cutaneous T-cell non-Hodgkin lymphoma | Not yet recruiting | Not stated | 2025-07-04 | NCT07046663 | |
| An Observational Study of Carbaglu® for the Treatment of MMA and PA in Adults and Pediatrics | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Hyperammonemia, Nutritional and Metabolic Diseases, Pathologic Processes, Pathological Conditions, Signs and Symptoms, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, methylmalonic acidemia, propionic acidemia | Recruiting | Not stated | 2025-04-15 | NCT05040178 | |
| Understanding the Long-Term Management of Organic Acidemia Patients With CARBAGLU®: A Mixed Methods Approach | Congenital, Hereditary, and Neonatal Diseases and Abnormalities, Nutritional and Metabolic Diseases, hereditary disease, inborn disorder of amino acid metabolism, inborn errors of metabolism, metabolic disease, methylmalonic acidemia, propionic acidemia | Recruiting | Not stated | 2024-02-05 | NCT04176523 |